FDA Approves Journavx Drug to Treat Pain Without Addiction Risknews2025-01-31T00:12:17+00:00January 31st, 2025|The New York Times|
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptionsnews2024-12-17T10:00:41+00:00December 17th, 2024|The New York Times|
How The Opioid Crisis Turned Pharmacists Into Copsnews2024-10-28T09:00:58+00:00October 28th, 2024|The New York Times|
Broken Again. A National Advocate for Drug Recovery Relapses.news2024-09-07T09:00:36+00:00September 7th, 2024|The New York Times|
The Painkiller Used for Just About Anythingnews2024-08-17T11:46:14+00:00August 17th, 2024|The New York Times|
Purdue Opioid Settlement on Verge of Collapse After Supreme Court Rulingnews2024-06-27T19:56:56+00:00June 27th, 2024|The New York Times|
Addiction Risk Scores Won’t Solve the Opioid Crisisnews2024-04-20T11:00:44+00:00April 20th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
